The All India Institute of Medical Sciences (AIIMS) based in New Delhi on Thursday invited volunteers for the Phase III clinical trial of the indigenously developed Covid-19 vaccine candidate ‘Covaxin’ for which it is one of the sites.
source https://www.hindustantimes.com/india-news/indian-vaccine-covaxin-has-drawn-global-attention-icmr/story-eq2WMqSlyzlOtjLeNNPyxI.html
No comments:
Post a Comment